Eckmann J: Difference between revisions
From Bioblast
No edit summary |
Nirschl Lisa (talk | contribs) No edit summary Β |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 9: | Line 9: | ||
|city=Frankfurt | |city=Frankfurt | ||
|country=Germany | |country=Germany | ||
}} | }} | ||
{{Labelingperson | |||
|field of research=Basic | |||
}} | |||
==Participated at== | |||
::::* [[MiP2011 | MiP2011 Bordeaux FR]] |
Latest revision as of 11:38, 13 February 2018
Name | Eckmann Janette, |
---|---|
Institution | Institute of Pharmacology
Biozentrum, GebΓ€ude N260 |
Address | Max-von-Laue-Str. 9, 60437 |
City | Frankfurt |
State/Province | |
Country | Germany |
[email protected] | |
Weblink | |
O2k-Network Lab | DE Frankfurt Eckert GP |
Labels:
Field of research: Basic
Publications
Published | Reference | |
---|---|---|
Eckmann 2014 Mol Neurobiol | 2014 | Eckmann J, Clemens LE, Eckert SH, Hagl S, Yu-Taeger L, Bordet T, Pruss RM, Muller WE, Leuner K, Nguyen HP, Eckert GP (2014) Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime. Mol Neurobiol 50:107-18. |
Eckert 2012 J Alzheimers Dis | 2012 | Eckert SH, Eckmann J, Renner-Sattler K, Eckert GP, Leuner K, Mueller WE (2012) Dimebon ameliorates Amyloid-Ξ² induced impairments of mitochondrial form and function. J Alzheimers Dis 31:21-32. |
Eckert 2012 Mol Neurobiol | 2012 | Eckert GP, Renner K, Eckert SH, Eckmann J, Hagl S, Abdel-Kader RM, Kurz C, Leuner K, Muller WE (2012) Mitochondrial dysfunction - a pharmacological target in Alzheimer's disease. Mol Neurobiol 46:136-50. |